BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32031216)

  • 1. Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?
    Kornbluth A
    Inflamm Bowel Dis; 2020 Oct; 26(11):1730-1732. PubMed ID: 32031216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mucosal healing in ulcerative colitis].
    Fujiya M; Kohgo Y
    Nihon Shokakibyo Gakkai Zasshi; 2013 Nov; 110(11):1900-8. PubMed ID: 24189817
    [No Abstract]   [Full Text] [Related]  

  • 3. Ulcerative colitis: UCCIS--a reproducible tool to assess mucosal healing.
    Neumann H; Neurath MF
    Nat Rev Gastroenterol Hepatol; 2012 Dec; 9(12):692-4. PubMed ID: 23070368
    [No Abstract]   [Full Text] [Related]  

  • 4. A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials.
    Li K; Strauss R; Marano C; Greenbaum LE; Friedman JR; Peyrin-Biroulet L; Brodmerkel C; De Hertogh G
    J Crohns Colitis; 2019 Aug; 13(8):1025-1035. PubMed ID: 30721964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough.
    Goodsall TM; Costello SP; Bryant RV
    J Crohns Colitis; 2020 Oct; 14(10):1341-1342. PubMed ID: 32602550
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of Endoscopic Healing by Using Advanced Technologies Reflects Histological Healing in Ulcerative Colitis.
    Iacucci M; Cannatelli R; Gui X; Zardo D; Bazarova A; Gkoutos GV; Lethebe BC; Kaplan GG; Panaccione R; Kiesslich R; Ghosh S
    J Crohns Colitis; 2020 Sep; 14(9):1282-1289. PubMed ID: 32201877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
    Cushing KC; Tan W; Alpers DH; Deshpande V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2020 Feb; 51(3):347-355. PubMed ID: 31696961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapeutic goals in inflammatory bowel diseases].
    Vuitton L; Peyrin-Biroulet L
    Rev Prat; 2014 Nov; 64(9):1232-6. PubMed ID: 25638861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic remission: the ultimate therapeutic goal in ulcerative colitis?
    Peyrin-Biroulet L; Bressenot A; Kampman W
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):929-34.e2. PubMed ID: 23911875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of mucosal healing in ulcerative colitis.
    Lichtenstein GR; Rutgeerts P
    Inflamm Bowel Dis; 2010 Feb; 16(2):338-46. PubMed ID: 19637362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?
    Mohammed N; Subramanian V
    World J Gastroenterol; 2016 Nov; 22(42):9324-9332. PubMed ID: 27895420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis.
    Church PC; Ho S; Sharma A; Tomalty D; Frost K; Muise A; Walters TD; Griffiths AM
    J Crohns Colitis; 2019 Aug; 13(8):982-989. PubMed ID: 30715240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing?
    Rubin DT
    Clin Gastroenterol Hepatol; 2011 Jun; 9(6):456-7. PubMed ID: 21421077
    [No Abstract]   [Full Text] [Related]  

  • 15. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
    Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
    Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal healing in ulcerative colitis: where do we stand?
    Fiorino G; Cesarini M; Indriolo A; Malesci A
    Curr Drug Targets; 2011 Sep; 12(10):1417-23. PubMed ID: 21466490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal healing in inflammatory bowel disease.
    Osterman MT
    J Clin Gastroenterol; 2013 Mar; 47(3):212-21. PubMed ID: 23340060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.
    Bálint A; Rutka M; Kolar M; Bortlik M; Duricova D; Hruba V; Lukas M; Mitrova K; Malickova K; Lukas M; Szepes Z; Nagy F; Palatka K; Lovas S; Végh Z; Kürti Z; Csontos Á; Miheller P; Nyári T; Bor R; Milassin Á; Fábián A; Szántó K; Lakatos PL; Molnár T; Farkas K
    Expert Opin Biol Ther; 2018 Nov; 18(11):1181-1187. PubMed ID: 30277084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How rapidly should remission be achieved?
    Isaacs KL
    Dig Dis; 2010; 28(3):548-55. PubMed ID: 20926885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.